Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 February 2025 | Story Vuyelwa Mbebe | Photo Supplied
Regional Committee SAACHS
The Kovsie Health staff members who also serve on the SAACHS regional committee: Shibashiba Moabelo, Riana Johnson, Sarien de Necker, Theresa de Vries, and Emmerencia Sibanda.

The University of the Free State (UFS) took centre stage at the annual South African Association of Campus Health Services (SAACHS) Conference, held at the Windmill Casino Conference Centre in Bloemfontein from 8 to 10 January 2025. 

The conference was themed ‘Student Centredness’ and brought together representatives from 22 higher education institutions to explore critical issues related to student health and wellness.

SAACHS is a national association comprising tertiary institutions that offer primary and occupational healthcare services on campuses across South Africa. This year’s conference covered a range of pressing topics, including HIV support for students, strategies to assist pregnant students, telehealth collaborations, caregiver self-care, student health-seeking behaviours, food insecurity, and best practices in campus health emergency medical services.

Sr Riana Johnson, Deputy Director of Kovsie Health and regional chair of the Free State and Northern Cape SAACHS committee, emphasised the impact of the UFS’s involvement. “The strong representation of UFS speakers highlighted the strides we have made in campus health services and the invaluable contributions our institution brings to these crucial discussions,” she said.

As key organisers, Johnson and her team – including Sr Sarien de Necker and colleagues from the UFS and the Central University of Technology (CUT) – were instrumental in securing speakers, selecting relevant topics, and managing conference logistics. Their efforts ensured the smooth running of an event that encouraged knowledge-sharing and collaboration among campus health professionals.

“The conference provided a vital platform for networking and exchanging ideas,” Johnson said. “UFS’s active participation helped strengthen partnerships with institutions such as the Department of Health and promoted shared solutions to student wellness challenges.”

She added that hosting the event underscored the UFS’s leadership in campus health and allowed other institutions to learn from its initiatives. Discussions and collaborations at the conference enhanced awareness campaigns and reinforced a collective commitment to student well-being.

Looking ahead, Johnson believes the insights gained will shape the future of Kovsie Health. “Exploring new health technologies and expanding student-centred health initiatives are among our top priorities,” she concluded. “The knowledge shared at this conference will undoubtedly influence how we evolve our services to meet the needs of our students more effectively.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept